JP2003525894A5 - - Google Patents

Download PDF

Info

Publication number
JP2003525894A5
JP2003525894A5 JP2001564741A JP2001564741A JP2003525894A5 JP 2003525894 A5 JP2003525894 A5 JP 2003525894A5 JP 2001564741 A JP2001564741 A JP 2001564741A JP 2001564741 A JP2001564741 A JP 2001564741A JP 2003525894 A5 JP2003525894 A5 JP 2003525894A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
oil
omeprazole
embedded image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001564741A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003525894A (ja
JP4663197B2 (ja
Filing date
Publication date
Priority claimed from SE0000773A external-priority patent/SE0000773D0/xx
Application filed filed Critical
Publication of JP2003525894A publication Critical patent/JP2003525894A/ja
Publication of JP2003525894A5 publication Critical patent/JP2003525894A5/ja
Application granted granted Critical
Publication of JP4663197B2 publication Critical patent/JP4663197B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001564741A 2000-03-08 2001-03-06 新規な自己乳化性薬物送達系 Expired - Fee Related JP4663197B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0000773A SE0000773D0 (sv) 2000-03-08 2000-03-08 New formulation
SE0000773-2 2000-03-08
PCT/SE2001/000467 WO2001066088A1 (en) 2000-03-08 2001-03-06 New self emulsifying drug delivery system

Publications (3)

Publication Number Publication Date
JP2003525894A JP2003525894A (ja) 2003-09-02
JP2003525894A5 true JP2003525894A5 (https=) 2008-04-17
JP4663197B2 JP4663197B2 (ja) 2011-03-30

Family

ID=20278739

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001564741A Expired - Fee Related JP4663197B2 (ja) 2000-03-08 2001-03-06 新規な自己乳化性薬物送達系

Country Status (30)

Country Link
US (1) US20030161846A1 (https=)
EP (1) EP1267832B1 (https=)
JP (1) JP4663197B2 (https=)
KR (1) KR100771317B1 (https=)
CN (2) CN101862453A (https=)
AT (1) ATE268162T1 (https=)
AU (2) AU3787601A (https=)
BR (1) BR0109014A (https=)
CA (1) CA2401498C (https=)
CZ (1) CZ20023005A3 (https=)
DE (1) DE60103627T2 (https=)
DK (1) DK1267832T3 (https=)
EE (1) EE200200500A (https=)
ES (1) ES2220728T3 (https=)
HU (1) HUP0300882A3 (https=)
IL (1) IL151427A0 (https=)
IS (1) IS6539A (https=)
MX (1) MXPA02008657A (https=)
MY (1) MY127237A (https=)
NO (1) NO20024272L (https=)
NZ (1) NZ521009A (https=)
PL (1) PL202683B1 (https=)
PT (1) PT1267832E (https=)
RU (1) RU2270675C9 (https=)
SE (1) SE0000773D0 (https=)
SK (1) SK285982B6 (https=)
TR (1) TR200401906T4 (https=)
UA (1) UA82979C2 (https=)
WO (1) WO2001066088A1 (https=)
ZA (1) ZA200206740B (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (sv) * 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
SE0200895D0 (sv) * 2002-03-22 2002-03-22 Astrazeneca Ab New pharmaceutical composition
ITMI20021392A1 (it) * 2002-06-25 2003-12-29 Nicox Sa Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
AU2003247792B2 (en) 2002-07-03 2009-09-24 Nicox S.A. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US7244753B2 (en) 2002-07-29 2007-07-17 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
EP1534278A4 (en) * 2002-08-01 2006-09-06 Nitromed Inc NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
SE0301880D0 (sv) * 2003-06-25 2003-06-25 Astrazeneca Uk Ltd New drug delivery composition
KR20050034299A (ko) * 2003-10-09 2005-04-14 한국유나이티드제약 주식회사 아세클로페낙 자가유화에멀젼 및 이를 이용한 연질캅셀제조성물 및 그의 제조방법
AU2006274098B2 (en) 2005-07-26 2012-02-09 Nicox Science Ireland Pharmaceutical formulation of nitrooxyderivatives of NSAIDs
EP1965774A2 (en) * 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
US9220698B2 (en) 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
MX2011005643A (es) * 2008-12-03 2011-09-27 Astellas Deutschland Gmbh Formas de dosificacion oral de bendamustina.
US20100273730A1 (en) * 2009-04-27 2010-10-28 Innopharmax, Inc. Self-emulsifying pharmaceutical compositions of hydrophilic drugs and preparation thereof
KR20120030106A (ko) 2009-06-25 2012-03-27 아스트라제네카 아베 Ｎｓａｉｄ-연관된 궤양의 발생 위험이 있는 환자의 치료 방법
MY154683A (en) * 2009-07-07 2015-07-15 Boehringer Ingelheim Int Pharmaceutical composition for a hepatitis c viral protease inhibitor
US9717703B2 (en) 2009-10-16 2017-08-01 Glaxosmithkline Llc Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID
CN102614115B (zh) * 2012-04-26 2013-05-15 河南中医学院 一种双氯芬酸钠自乳化软膏
EP3043648B1 (en) 2013-08-27 2023-09-20 Vasilios VOUDOURIS Bendamustine pharmaceutical compositions
MY185428A (en) * 2015-01-21 2021-05-19 Mochida Pharm Co Ltd Self-emulsifying composition of ?-3 fatty acid
MX387217B (es) * 2015-08-07 2025-03-18 Infirst Healthcare Ltd Composiciones de solución sólida para aines.
CN113440481B (zh) * 2021-08-13 2022-06-14 湖南慧泽生物医药科技有限公司 伊布替尼的自微乳组合物

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US4766117A (en) * 1984-10-11 1988-08-23 Pfizer Inc. Antiinflammatory compositions and methods
US4704278A (en) * 1984-10-17 1987-11-03 American Home Products Corp (Del) Fluidized magaldrate suspension
US4676984A (en) * 1985-08-14 1987-06-30 American Home Products Corp. Rehydratable antacid composition
US5037815A (en) * 1986-03-04 1991-08-06 Bristol-Myers Squibb Co. Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
US4965065A (en) * 1986-04-29 1990-10-23 Bristol-Myers Squibb Company Gastroprotective process and compositions
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
US5043358A (en) * 1986-03-04 1991-08-27 Bristol-Myers Squibb Company Gastroprotective process
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
US5204118A (en) * 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
JPH06506198A (ja) * 1991-03-04 1994-07-14 ワーナー−ランバート・コンパニー 種々な剤形の非ステロイド性抗炎症剤の新規な塩／イオン対
DK0550083T3 (da) * 1991-12-06 1999-10-11 Glaxo Group Ltd Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
IT1256345B (it) * 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
IT1256450B (it) * 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DK66493D0 (da) * 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
US6312704B1 (en) * 1993-09-30 2001-11-06 Gattefosse, S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US6054136A (en) * 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
FR2710535B1 (fr) * 1993-09-30 1995-11-24 Gattefosse Ets Sa Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.
EP0722434B1 (en) * 1993-10-06 1998-07-29 Nicox S.A. Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
JP3725542B2 (ja) * 1993-10-19 2005-12-14 大正製薬株式会社 ピコサルフェート剤形
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5643960A (en) * 1994-04-15 1997-07-01 Duke University Method of delaying onset of alzheimer's disease symptoms
US6025395A (en) * 1994-04-15 2000-02-15 Duke University Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
WO1995030641A1 (en) * 1994-05-10 1995-11-16 Nicox S.A. Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
EP0760237A1 (en) * 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6231888B1 (en) * 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
US6160020A (en) * 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510643C2 (sv) * 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
HU228923B1 (en) * 1997-07-29 2013-06-28 Upjohn Co Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
CA2307887A1 (en) * 1997-10-31 1999-05-14 Monsanto Company Gellan gum tablet coating
WO1999038512A1 (en) * 1998-01-30 1999-08-05 Sepracor Inc. S-lansoprazole compositions and methods
WO1999038513A1 (en) * 1998-01-30 1999-08-05 Sepracor Inc. R-lansoprazole compositions and methods
CA2331640A1 (en) * 1998-05-07 1999-11-11 Elan Corporation Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
EP0984012A3 (en) * 1998-08-31 2001-01-10 Pfizer Products Inc. Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
MXPA01003197A (es) * 1998-09-28 2004-04-21 Warner Lambert Co Suministro enterico y colonico utilizando capsulas de chpm.
US6485747B1 (en) * 1998-10-30 2002-11-26 Monsanto Company Coated active tablet(s)
US6638522B1 (en) * 1998-12-11 2003-10-28 Pharmasolutions, Inc. Microemulsion concentrate composition of cyclosporin
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6126816A (en) * 1999-07-14 2000-10-03 Ruiz, Jr.; Reuben F. Wastewater treatment device
US6787164B2 (en) * 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
SE0002476D0 (sv) * 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6544556B1 (en) * 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
US20020045184A1 (en) * 2000-10-02 2002-04-18 Chih-Ming Chen Packaging system
FR2818905A1 (fr) * 2000-12-28 2002-07-05 Cll Pharma Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile

Similar Documents

Publication Publication Date Title
JP2003525894A5 (https=)
CA2401498A1 (en) New self emulsifying drug delivery system
JP2003525893A5 (https=)
JP2003500442A5 (https=)
RU2000116011A (ru) Пероральная фармацевтическая лекарственная форма с продолжительным высвобождением
RU96120189A (ru) Новые фармацевтические препараты и способы их получения
JP2005518423A5 (https=)
US20100099766A1 (en) Topical NSAID compositions having sensate component
RU2001135826A (ru) Новое применение соединений в качестве антибактериальных средств
PL191780B1 (pl) Kompozycja farmaceutyczna w postaci samoemulgującej formulacji związków lipofilowych i samoemulgujące podłoże formulacji
CA2294032A1 (en) Self-emulsifying formulation for lipophilic compounds
RU2013110820A (ru) Применение связывающих средств для получения стабильных при хранениии составов
CA2373653A1 (en) New use of compounds as antibacterial agents
RU2000124535A (ru) Вводимая оральным путем галенова форма с быстрым высвобождением и с пролонгированным высвобождением, включающая усиливающий абсорбцию агент, и применение этого усиливающего абсорбцию агента
KR20080071185A (ko) 부프레노르핀을 포함하는 약제학적 조성물
RU2007139819A (ru) Композиции с гидрофильными лекарствами в гидрофобной среде
ES2282408T3 (es) 15-ceto-prostaglandina para el tratamiento de estreñimiento por farmaco.
JP2003521471A5 (https=)
AU2001237876A1 (en) New self emulsifying drug delivery system
JP2003508434A5 (https=)
RU2002122745A (ru) Новая самоэмульгирующаяся система доставки лекарств
JPH01268633A (ja) Ｌ−ドーパの直腸被吸収性形態
US7815933B2 (en) Self emulsifying drug delivery system
RU2002110328A (ru) Препарат замещенных бензимидазолов
CA2425199A1 (en) Formulation of substituted benzimidazoles